A reverse Warburg metabolism in oral squamous cell carcinoma is not dependent upon myofibroblasts

Journal of Oral Pathology and Medicine

Volumn 44, Issue 9, 2015, Pages 714-721

  Jensen, David H ^a   Therkildsen, Marianne H ^a   Dabelsteen, Erik ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Myofibroblast; Oral squamous cell carcinoma; Reverse Warburg effect

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CAVEOLIN 1; GLUCOSE TRANSPORTER 1; KI 67 ANTIGEN; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 4; PEPTIDES AND PROTEINS; PROTEIN TOMM20; UNCLASSIFIED DRUG; ACTA2 PROTEIN, HUMAN; ACTIN; COTRANSPORTER; MONOCARBOXYLATE TRANSPORT PROTEIN 1; MONOCARBOXYLATE TRANSPORTER; MUSCLE PROTEIN; SLC16A4 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MOUTH SQUAMOUS CELL CARCINOMA; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE WARBURG METABOLISM; AGED; ANIMAL; BREAST NEOPLASMS; EPITHELIUM; FIBROBLAST; HEAD AND NECK TUMOR; IMMUNOLOGY; MIDDLE AGED; MOUSE; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; RABBIT; SQUAMOUS CELL CARCINOMA; STROMA CELL;

ACTINS; AGED; ANIMALS; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CAVEOLIN 1; EPITHELIUM; FEMALE; FIBROBLASTS; GLUCOSE TRANSPORTER TYPE 1; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICE; MIDDLE AGED; MONOCARBOXYLIC ACID TRANSPORTERS; MOUTH NEOPLASMS; MUSCLE PROTEINS; MYOFIBROBLASTS; PROGNOSIS; RABBITS; STROMAL CELLS; SYMPORTERS;

EID: 84942885449     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12297     Document Type: Article

References (31)

1. Warburg O. Über den Stoffwechsel der Carcinomzelle. Naturwissenschaften 1924; 12: 1131-7.
2. Pavlides S, Whitaker-Menezes D, Castello-Cros R, et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009a; 8: 3984-4001.
3. Witkiewicz AK, Dasgupta A, Sotgia F, et al. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 2009; 174: 2023-34.
4. Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, et al. Evidence for a stromal-epithelial 'lactate shuttle' in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 2011a; 10: 1772-83.
5. Bello IO, Vered M, Dayan D, et al. Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer. Oral Oncol 2011; 47: 33-8.
6. Marsh D, Suchak K, Moutasim KA, et al. Stromal features are predictive of disease mortality in oral cancer patients. J Pathol 2011; 223: 470-81.
7. Vered M, Dobriyan A, Dayan D, et al. Tumor-host histopathologic variables, stromal myofibroblasts and risk score, are significantly associated with recurrent disease in tongue cancer. Cancer Sci 2010; 101: 274-80.
8. Sobral LM, Bufalino A, Lopes MA, et al. Myofibroblasts in the stroma of oral cancer promote tumorigenesis via secretion of activin A. Oral Oncol 2011; 47: 840-6.
9. Lewis MP, Lygoe KA, Nystrom ML, et al. Tumour-derived TGF-[beta]1 modulates myofibroblast differentiation and promotes HGF//SF-dependent invasion of squamous carcinoma cells. Br J Cancer 2004; 90: 822-32.
10. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003; 200: 429-47.
11. Kellermann MG, Sobral LM, Silva SDD, et al. Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology 2007; 51: 849-53.
12. Barnes L. Pathology and genetics of head and neck tumours. IARC, 2005.
13. Whitaker-Menezes D, Martinez-Outschoorn UE, Flomenberg N, et al. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle 2011b; 10: 4047.
14. Sato M, Nakai Y, Nakata W, et al. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. PLoS ONE 2013; 8: e74313.
15. Guido C, Whitaker-Menezes D, Lin Z, et al. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth. Oncotarget 2012; 3: 798.
16. Humar B, Fukuzawa R, Blair V, et al. Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Res 2007; 67: 2480-9.
17. Pyla R, Poulose N, Jun JY, et al. Expression of conventional and novel glucose transporters, GLUT1, -9, -10, and-12, in vascular smooth muscle cells. Am J Physiol Cell Physiol 2013; 304: C574-89.
18. Uhlen M, Oksvold P, Fagerberg L, et al. Towards a knowledge-based human protein atlas. Nat Biotechnol 2010; 28: 1248-50.
19. Larsson L-I. A novel immunocytochemical model system for specificity and sensitivity screening of antisera against multiple antigens. J Histochem Cytochem 1981; 29: 408-10.
20. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029-33.
21. Lee EK, Lee YS, Han I-O, et al. Expression of caveolin-1 reduces cellular responses to TGF-β1 through down-regulating the expression of TGF-β type II receptor gene in NIH3T3 fibroblast cells. Biochem Biophys Res Commun 2007; 359: 385-90.
22. Zhu J, Wu Y-N, Zhang W, et al. Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patients. PLoS ONE 2014; 9: e87904.
23. Curry JM, Tuluc M, Whitaker-Menezes D, et al. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. Cell Cycle 2013; 12: 1371.
24. Wolff K, Hönigsmann H. Permeability of the epidermis and the phagocytic activity of keratinocytes: ultrastructural studies with thorotrast as a marker. J Ultrastruct Res 1971; 36: 176-90.
25. Tolo K. Penetration of human albumin through the oral mucosa of guinea-pigs immunized to this protein. Arch Oral Biol 1974; 19: 259-63.
26. Cairns RA, Harris IS. Mak TW Regulation of cancer cell metabolism. Nat Rev Cancer 2011; 11: 85-95.
27. Ullah MS, DavieS AJ, Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1α-dependent mechanism. J Biol Chem 2006; 281: 9030-7.
28. Blagosklonny MV. Hypoxia-inducible factor: Achilles' heel of antiangiogenic cancer therapy (Review). Int J Oncol 2001; 19: 257-62.
29. Pennacchietti S, Michieli P, Galluzzo M, et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003; 3: 347-61.
30. Blagosklonny MV. Antiangiogenic therapy and tumor progression. Cancer Cell 2004; 5: 13-7.
31. Grépin R, Pagès G. Molecular mechanisms of resistance to tumour anti-angiogenic strategies. J Oncol 2010; 2010: 835680.